Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition

Jeffrey Cummings, Jacobo Mintzer, Henry Brodaty, Mary Sano, Sube Banerjee, D. P. Devanand, Serge Gauthier, Robert Howard, Krista Lanctôt, Constantine G Lyketsos, Elaine Peskind, Anton P. Porsteinsson, Edgardo Reich, Cristina Sampaio, David Steffens, Marc Wortmann, Kate Zhong

Research output: Contribution to journalArticle

Abstract

Background: Agitation is common across neuropsychiatric disorders and contributes to disability, institutionalization, and diminished quality of life for patients and their caregivers. There is no consensus definition of agitation and no widespread agreement on what elements should be included in the syndrome. The International Psychogeriatric Association formed an Agitation Definition Work Group (ADWG) to develop a provisional consensus definition of agitation in patients with cognitive disorders that can be applied in epidemiologic, non-interventional clinical, pharmacologic, non-pharmacologic interventional, and neurobiological studies. A consensus definition will facilitate communication and cross-study comparison and may have regulatory applications in drug development programs. Methods: The ADWG developed a transparent process using a combination of electronic, face-to-face, and survey-based strategies to develop a consensus based on agreement of a majority of participants. Nine-hundred twenty-eight respondents participated in the different phases of the process. Results: Agitation was defined broadly as: (1) occurring in patients with a cognitive impairment or dementia syndrome; (2) exhibiting behavior consistent with emotional distress; (3) manifesting excessive motor activity, verbal aggression, or physical aggression; and (4) evidencing behaviors that cause excess disability and are not solely attributable to another disorder (psychiatric, medical, or substance-related). A majority of the respondents rated all surveyed elements of the definition as strongly agree or somewhat agree (68-88% across elements). A majority of the respondents agreed that the definition is appropriate for clinical and research applications. Conclusions: A provisional consensus definition of agitation has been developed. This definition can be used to advance interventional and non-interventional research of agitation in patients with cognitive impairment.

Original languageEnglish (US)
Pages (from-to)7-17
Number of pages11
JournalInternational Psychogeriatrics
Volume27
Issue number1
DOIs
StatePublished - Jan 12 2015

Fingerprint

Consensus
Aggression
Research
Institutionalization
Caregivers
Psychiatry
Dementia
Motor Activity
Communication
Quality of Life
Surveys and Questionnaires
Pharmaceutical Preparations
Cognitive Dysfunction

Keywords

  • aggression
  • agitation
  • Alzheimer's disease
  • clinical trials
  • cognitive impairment
  • epidemiology
  • Food and Drug Administration
  • International Psychogeriatric Association
  • intervention

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Gerontology
  • Clinical Psychology

Cite this

Agitation in cognitive disorders : International Psychogeriatric Association provisional consensus clinical and research definition. / Cummings, Jeffrey; Mintzer, Jacobo; Brodaty, Henry; Sano, Mary; Banerjee, Sube; Devanand, D. P.; Gauthier, Serge; Howard, Robert; Lanctôt, Krista; Lyketsos, Constantine G; Peskind, Elaine; Porsteinsson, Anton P.; Reich, Edgardo; Sampaio, Cristina; Steffens, David; Wortmann, Marc; Zhong, Kate.

In: International Psychogeriatrics, Vol. 27, No. 1, 12.01.2015, p. 7-17.

Research output: Contribution to journalArticle

Cummings, J, Mintzer, J, Brodaty, H, Sano, M, Banerjee, S, Devanand, DP, Gauthier, S, Howard, R, Lanctôt, K, Lyketsos, CG, Peskind, E, Porsteinsson, AP, Reich, E, Sampaio, C, Steffens, D, Wortmann, M & Zhong, K 2015, 'Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition', International Psychogeriatrics, vol. 27, no. 1, pp. 7-17. https://doi.org/10.1017/S1041610214001963
Cummings, Jeffrey ; Mintzer, Jacobo ; Brodaty, Henry ; Sano, Mary ; Banerjee, Sube ; Devanand, D. P. ; Gauthier, Serge ; Howard, Robert ; Lanctôt, Krista ; Lyketsos, Constantine G ; Peskind, Elaine ; Porsteinsson, Anton P. ; Reich, Edgardo ; Sampaio, Cristina ; Steffens, David ; Wortmann, Marc ; Zhong, Kate. / Agitation in cognitive disorders : International Psychogeriatric Association provisional consensus clinical and research definition. In: International Psychogeriatrics. 2015 ; Vol. 27, No. 1. pp. 7-17.
@article{d54e98a6872e4e5db098d0b694f4125a,
title = "Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition",
abstract = "Background: Agitation is common across neuropsychiatric disorders and contributes to disability, institutionalization, and diminished quality of life for patients and their caregivers. There is no consensus definition of agitation and no widespread agreement on what elements should be included in the syndrome. The International Psychogeriatric Association formed an Agitation Definition Work Group (ADWG) to develop a provisional consensus definition of agitation in patients with cognitive disorders that can be applied in epidemiologic, non-interventional clinical, pharmacologic, non-pharmacologic interventional, and neurobiological studies. A consensus definition will facilitate communication and cross-study comparison and may have regulatory applications in drug development programs. Methods: The ADWG developed a transparent process using a combination of electronic, face-to-face, and survey-based strategies to develop a consensus based on agreement of a majority of participants. Nine-hundred twenty-eight respondents participated in the different phases of the process. Results: Agitation was defined broadly as: (1) occurring in patients with a cognitive impairment or dementia syndrome; (2) exhibiting behavior consistent with emotional distress; (3) manifesting excessive motor activity, verbal aggression, or physical aggression; and (4) evidencing behaviors that cause excess disability and are not solely attributable to another disorder (psychiatric, medical, or substance-related). A majority of the respondents rated all surveyed elements of the definition as strongly agree or somewhat agree (68-88{\%} across elements). A majority of the respondents agreed that the definition is appropriate for clinical and research applications. Conclusions: A provisional consensus definition of agitation has been developed. This definition can be used to advance interventional and non-interventional research of agitation in patients with cognitive impairment.",
keywords = "aggression, agitation, Alzheimer's disease, clinical trials, cognitive impairment, epidemiology, Food and Drug Administration, International Psychogeriatric Association, intervention",
author = "Jeffrey Cummings and Jacobo Mintzer and Henry Brodaty and Mary Sano and Sube Banerjee and Devanand, {D. P.} and Serge Gauthier and Robert Howard and Krista Lanct{\^o}t and Lyketsos, {Constantine G} and Elaine Peskind and Porsteinsson, {Anton P.} and Edgardo Reich and Cristina Sampaio and David Steffens and Marc Wortmann and Kate Zhong",
year = "2015",
month = "1",
day = "12",
doi = "10.1017/S1041610214001963",
language = "English (US)",
volume = "27",
pages = "7--17",
journal = "International Psychogeriatrics",
issn = "1041-6102",
publisher = "Cambridge University Press",
number = "1",

}

TY - JOUR

T1 - Agitation in cognitive disorders

T2 - International Psychogeriatric Association provisional consensus clinical and research definition

AU - Cummings, Jeffrey

AU - Mintzer, Jacobo

AU - Brodaty, Henry

AU - Sano, Mary

AU - Banerjee, Sube

AU - Devanand, D. P.

AU - Gauthier, Serge

AU - Howard, Robert

AU - Lanctôt, Krista

AU - Lyketsos, Constantine G

AU - Peskind, Elaine

AU - Porsteinsson, Anton P.

AU - Reich, Edgardo

AU - Sampaio, Cristina

AU - Steffens, David

AU - Wortmann, Marc

AU - Zhong, Kate

PY - 2015/1/12

Y1 - 2015/1/12

N2 - Background: Agitation is common across neuropsychiatric disorders and contributes to disability, institutionalization, and diminished quality of life for patients and their caregivers. There is no consensus definition of agitation and no widespread agreement on what elements should be included in the syndrome. The International Psychogeriatric Association formed an Agitation Definition Work Group (ADWG) to develop a provisional consensus definition of agitation in patients with cognitive disorders that can be applied in epidemiologic, non-interventional clinical, pharmacologic, non-pharmacologic interventional, and neurobiological studies. A consensus definition will facilitate communication and cross-study comparison and may have regulatory applications in drug development programs. Methods: The ADWG developed a transparent process using a combination of electronic, face-to-face, and survey-based strategies to develop a consensus based on agreement of a majority of participants. Nine-hundred twenty-eight respondents participated in the different phases of the process. Results: Agitation was defined broadly as: (1) occurring in patients with a cognitive impairment or dementia syndrome; (2) exhibiting behavior consistent with emotional distress; (3) manifesting excessive motor activity, verbal aggression, or physical aggression; and (4) evidencing behaviors that cause excess disability and are not solely attributable to another disorder (psychiatric, medical, or substance-related). A majority of the respondents rated all surveyed elements of the definition as strongly agree or somewhat agree (68-88% across elements). A majority of the respondents agreed that the definition is appropriate for clinical and research applications. Conclusions: A provisional consensus definition of agitation has been developed. This definition can be used to advance interventional and non-interventional research of agitation in patients with cognitive impairment.

AB - Background: Agitation is common across neuropsychiatric disorders and contributes to disability, institutionalization, and diminished quality of life for patients and their caregivers. There is no consensus definition of agitation and no widespread agreement on what elements should be included in the syndrome. The International Psychogeriatric Association formed an Agitation Definition Work Group (ADWG) to develop a provisional consensus definition of agitation in patients with cognitive disorders that can be applied in epidemiologic, non-interventional clinical, pharmacologic, non-pharmacologic interventional, and neurobiological studies. A consensus definition will facilitate communication and cross-study comparison and may have regulatory applications in drug development programs. Methods: The ADWG developed a transparent process using a combination of electronic, face-to-face, and survey-based strategies to develop a consensus based on agreement of a majority of participants. Nine-hundred twenty-eight respondents participated in the different phases of the process. Results: Agitation was defined broadly as: (1) occurring in patients with a cognitive impairment or dementia syndrome; (2) exhibiting behavior consistent with emotional distress; (3) manifesting excessive motor activity, verbal aggression, or physical aggression; and (4) evidencing behaviors that cause excess disability and are not solely attributable to another disorder (psychiatric, medical, or substance-related). A majority of the respondents rated all surveyed elements of the definition as strongly agree or somewhat agree (68-88% across elements). A majority of the respondents agreed that the definition is appropriate for clinical and research applications. Conclusions: A provisional consensus definition of agitation has been developed. This definition can be used to advance interventional and non-interventional research of agitation in patients with cognitive impairment.

KW - aggression

KW - agitation

KW - Alzheimer's disease

KW - clinical trials

KW - cognitive impairment

KW - epidemiology

KW - Food and Drug Administration

KW - International Psychogeriatric Association

KW - intervention

UR - http://www.scopus.com/inward/record.url?scp=84927697456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927697456&partnerID=8YFLogxK

U2 - 10.1017/S1041610214001963

DO - 10.1017/S1041610214001963

M3 - Article

C2 - 25311499

AN - SCOPUS:84927697456

VL - 27

SP - 7

EP - 17

JO - International Psychogeriatrics

JF - International Psychogeriatrics

SN - 1041-6102

IS - 1

ER -